Patients with amyotrophic lateral sclerosis (ALS) have a different functional brain network than healthy individuals, and that difference appears to be strongly associated with disability, according to new research. This finding supports previous research suggesting that monitoring a patient’s brain for changes in its neuronal network can aid in evaluating ALS disability and likely disease progression. The study,…
Brains of ALS Patients ‘Wired’ Differently and That’s Evident in Disability, Study Says
The National Collegiate Athletic Association (NCAA) will honor Pete Frates, a former university baseball player who has amyotrophic lateral sclerosis (ALS), with its 2017 Inspiration Award for his perseverance, dedication and determination, and for being a role model and source of hope to others. The NCAA Honors Celebration will take place…
6 Tips to Help You Manage ALS
While there is currently no treatment that can either slow down or reverse the damage of amyotrophic lateral sclerosis (ALS), there are ways to make patients as comfortable as possible at each stage of the disease and to improve their quality of life. We’ve put together a list of some…
How Motor Neurons Form from Stem Cells Seen in Study That May Move ALS Cell Therapy Step Forward
The molecular steps taken to turn immature stem cells into working motor neurons were seen in new research, potentially furthering cell therapies to treat neurological disorders like amyotrophic lateral sclerosis (ALS) by teaching scientists more about this complex process. The study, “A Multi-Step Transcriptional And Chromatin State Cascade Underlies Motor Neuron Programming From Embryonic Stem Cells,” was published…
BrainStorm Cell Therapeutics recently presented data from its Phase 2 clinical trial, showing that the company’s NurOwn stem cells technology may halt disease progression in patients with amyotrophic lateral sclerosis (ALS). The data were presented at the 27th International Symposium on ALS/MND in Dublin, Ireland. The multi-center, randomized, double blind, placebo-controlled,…
6 Therapies Needed for ALS Patients
While there is currently no treatment that can either slow down or reverse the damage of amyotrophic lateral sclerosis (ALS), there are ways to make patients as comfortable as possible at each stage of the disease and to improve their quality of life. We’ve compiled a list of the therapies…
A single-case study of a patient with amyotrophic lateral sclerosis (ALS) suggests that long-term invasive motor cortex stimulation via implants of electrodes may slow progression of the disease. The study, “Reduction of disease progression in a patient with amyotrophic lateral sclerosis after several years of epidural motor cortex stimulation” was published…
New types of genetically engineered mice that allow scientists to study brain cells called astrocytes are expected to advance the understanding of how the cells contribute to diseases such as amyotrophic lateral sclerosis (ALS). Inserting a gene sequence in a specific position makes it possible for researchers to turn a…
Nursing a Patient With ALS
In this EmpowerRN video shared in March 2015, Caroline, a registered nurse, talks us through the signs, symptoms and treatments for amyotrophic lateral sclerosis (ALS) and how the disease progresses from initial symptoms to end of life. Discover seven facts about amyotrophic lateral sclerosis you might find…
Cytokinetics recently presented patient baseline characteristics from its VITALITY-ALS clinical trial investigating Tirasemtiv for the treatment of amyotrophic lateral sclerosis (ALS). Data collected from an international physician survey on the use of noninvasive ventilation (NIV) in the treatment of ALS also was presented. Both presentations were made at the…
Recent Posts
- New rare gene variants tied to ALS risk in large international genetic analysis
- ALS patients, caregivers prefer team-based care model, new survey finds
- ALS partnership to give 6 patients expanded access to TRE-515
- Frustration mounts when ALS assistive technology isn’t so helpful
- Trial of experimental ALS therapy pridopidine enrolls first participant